Cargando…

Integrated Clinical, Molecular and Immunological Characterization of Pulmonary Sarcomatoid Carcinomas Reveals an Immune Escape Mechanism That May Influence Therapeutic Strategies

Pulmonary sarcomatoid carcinoma (PSC) has highly aggressive biological behaviour and poor clinical outcomes, raising expectations for new therapeutic strategies. We characterized 179 PSC by immunohistochemistry, next-generation sequencing and in silico analysis using a deep learning algorithm with r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephan-Falkenau, Susann, Streubel, Anna, Mairinger, Thomas, Blum, Torsten-Gerriet, Kollmeier, Jens, Mairinger, Fabian D., Bauer, Torsten, Pfannschmidt, Joachim, Hollmann, Manuel, Wessolly, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341842/ https://www.ncbi.nlm.nih.gov/pubmed/37445733 http://dx.doi.org/10.3390/ijms241310558

Ejemplares similares

Landscape of Genomic Alterations and PD-L1 Expression in Early-Stage Non-Small-Cell Lung Cancer (NSCLC)—A Single Center, Retrospective Observational Study
por: Stephan-Falkenau, Susann, et al.
Publicado: (2022)

Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
por: Wessolly, Michael, et al.
Publicado: (2022)

A Novel Epitope Quality-Based Immune Escape Mechanism Reveals Patient’s Suitability for Immune Checkpoint Inhibition
por: Wessolly, Michael, et al.
Publicado: (2020)

Comparison of different semi-automated cfDNA extraction methods in combination with UMI-based targeted sequencing
por: Streubel, Anna, et al.
Publicado: (2019)

The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study
por: Boch, Christian, et al.
Publicado: (2013)

Morphometrical analysis of transbronchial cryobiopsies
por: Griff, Sergej, et al.
Publicado: (2011)

Erratum to: Morphometrical analysis of transbronchial cryobiopsies
por: Griff, Sergej, et al.
Publicado: (2016)

Digital Gene Expression Analysis of Epithelioid and Sarcomatoid Mesothelioma Reveals Differences in Immunogenicity
por: Brcic, Luka, et al.
Publicado: (2021)

Processing Escape Mechanisms Through Altered Proteasomal Cleavage of Epitopes Affect Immune Response in Pulmonary Neuroendocrine Tumors
por: Wessolly, Michael, et al.
Publicado: (2018)

One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy
por: Hager, Thomas, et al.
Publicado: (2023)

Autoimmune disorders and paraneoplastic syndromes in thymoma
por: Blum, Torsten Gerriet, et al.
Publicado: (2020)

Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer
por: Misch, Daniel, et al.
Publicado: (2015)

Diagnostic yield of transbronchial cryobiopsy in non-neoplastic lung disease: a retrospective case series
por: Griff, Sergej, et al.
Publicado: (2014)

Cancer-Associated Fibroblasts Influence Survival in Pleural Mesothelioma: Digital Gene Expression Analysis and Supervised Machine Learning Model
por: Borchert, Sabrina, et al.
Publicado: (2023)

Mitogen signal-associated pathways, energy metabolism regulation, and mediation of tumor immunogenicity play essential roles in the cellular response of malignant pleural mesotheliomas to platinum-based treatment: a retrospective study
por: Mathilakathu, Alexander, et al.
Publicado: (2021)

Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target
por: Greimelmaier, K., et al.
Publicado: (2023)

Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy
por: Mairinger, Fabian D., et al.
Publicado: (2018)

Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
por: Borchert, Sabrina, et al.
Publicado: (2019)

Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
por: Walter, Robert F. H., et al.
Publicado: (2018)

CAF-Associated Paracrine Signaling Worsens Outcome and Potentially Contributes to Chemoresistance in Epithelial Ovarian Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma
por: Mairinger, Fabian Dominik, et al.
Publicado: (2017)

Screening of Pleural Mesothelioma Cell Lines for Kinase Activity May Identify New Mechanisms of Therapy Resistance in Patients Receiving Platin-Based Chemotherapy
por: Borchert, Sabrina, et al.
Publicado: (2019)

Induction of metallothionein expression by supplementation of zinc induces resistance against platinum-based treatment in malignant pleural mesothelioma
por: Wyrich, Martine, et al.
Publicado: (2023)

Cancer-Associated Fibroblasts Regulate Kinase Activity in Mesothelioma Cell Lines via Paracrine Signaling and Thereby Dictate Cell Faith and Behavior
por: Mathilakathu, Alexander, et al.
Publicado: (2022)

Tumor cell cytoplasmic metallothionein expression associates with differential tumor immunogenicity and prognostic outcome in high-grade serous ovarian carcinoma
por: Mairinger, Elena, et al.
Publicado: (2023)

Narrow band imaging (NBI) during medical thoracoscopy: first impressions
por: Schönfeld, Nicolas, et al.
Publicado: (2009)

Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study
por: Xanthopoulos, Athanasios, et al.
Publicado: (2008)

Bortezomib sensitivity is tissue dependent and high expression of the 20S proteasome precludes good response in malignant pleural mesothelioma
por: Walter, Robert Fred Henry, et al.
Publicado: (2019)

Determinants of plasma calretinin in patients with malignant pleural mesothelioma
por: Lehnert, Martin, et al.
Publicado: (2020)

Highlights of thoracic oncology from the 2018 ERS International Congress
por: Ntontsi, Polyxeni, et al.
Publicado: (2019)

ERS International Congress, Madrid, 2019: highlights from the Thoracic Oncology Assembly
por: Costantini, Adrien, et al.
Publicado: (2020)

Implementation of data-dependent isotopologue fragmentation in (13)C-based metabolic flux analysis
por: Mairinger, Teresa, et al.
Publicado: (2017)

PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma
por: Al-Ghazzawi, Karim, et al.
Publicado: (2023)

KRAS(G12C)/TP53 co-mutations identify long-term responders to first line palliative treatment with pembrolizumab monotherapy in PD-L1 high (≥50%) lung adenocarcinoma
por: Frost, Nikolaj, et al.
Publicado: (2021)

Impact of metallothionein-knockdown on cisplatin resistance in malignant pleural mesothelioma
por: Borchert, Sabrina, et al.
Publicado: (2020)

Digital Immune-Related Gene Expression Signatures In High-Grade Serous Ovarian Carcinoma: Developing Prediction Models For Platinum Response
por: Mairinger, Fabian, et al.
Publicado: (2019)

Acceptance of Telepathology in Daily Practice
por: Mairinger, Thomas
Publicado: (2000)

Massive parallel sequencing and digital gene expression analysis reveals potential mechanisms to overcome therapy resistance in pulmonary neuroendocrine tumors
por: Walter, Robert Fred Henry, et al.
Publicado: (2016)

New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey
por: Berghmans, Thierry, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d9r4v45foqedeatjmo97mkt8d4